Cancers · 2019 · 28 citations · 25 references
MedicineOncologyPharmacologyApoptosisMolecular OncologyRadiobiologyBiological Effects Of RadiationMalignant NeoplasmsRadiation TherapyRadiation ToxicityRadiation-induced Cell DeathRadiation-induced SenescenceApoptosis After IrradiationBrca2 InactivationCancer Cell Proliferation InhibitionDna Damage InductionDna Damage-induced Cell DeathFlow Cytometric AnalysisRadiation-induced ApoptosisRna Polymerase I Activity
An increased rate of cellular proliferation is a hallmark of cancer and may be accompanied by an increase in ribosome biogenesis and dysregulation in rRNA synthesis. In this regard, CX-5461 has been developed as a novel RNA polymerase I inhibitor and is currently in Phase I/II clinical trials for solid and hematological malignancies. In the present study, interactions between CX-5461 and single-dose X-ray exposure were assessed using isobologram analysis using MTS assay and drug-induced cell death was assessed using flow cytometric, confocal microscopy and Western blot analysis. Combination treatments involving CX-5461 and single-dose X-ray exposure highlighted increased effectiveness compared to individual treatment alone in the CaSki cervical cancer line, with marked synergistic interaction occurring within the low-drug (50 nM) and low-dose radiation range (2–6 Gy). Cell lines challenged with CX-5461 demonstrated the presence of DNA damage, induction of apoptosis, autophagy and senescence alongside high percentages of G2/M cell cycle arrest. In addition, we report preferential sensitivity of ovarian cancer cells with BRCA2 mutation to this novel agent. Taken together, CX-5461 displayed a broad spectrum of activity in a panel of solid cancer cell lines with IC50 values ranging from 35 nM to >1 µM. The work described herein identifies the synergistic effects of CX-5461 in combination with X-rays in solid cancers and may also aid in the design of clinical trials involving this novel agent.
25
Directed Proteomic Analysis of the Human Nucleolus
Jens Andersen, Carol E. Lyon, Archa H. Fox et al. · Current Biology · 2002 · 1K citations · Full text